Skip to content

A study to check the effect of wound dressing in long standing wounds of leg

A prospective, single-arm study to assess the effectiveness and safety of Theruptor Novo dressing pad in the treatment of chronic lower extremity wounds

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049571
Enrollment
49
Registered
2023-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L979- Non-pressure chronic ulcer of unspecified part of lower leg

Interventions

Intervention1: 3D hydrocellular dressing pad: 3D hydrocellular dressing pad is made of Polyethylene terephthalate (PET), polyurethane (PU) and Dimethyl Tetradecyl [3(trimethoxysily) propyl] ammonium c

Sponsors

Dr Sanjay Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female patients aged above 18 years with 2. Patient with a low to moderate exuding lower extremity wound with size 3. Patient willing to give written informed consent and adhere to study procedures

Exclusion criteria

Exclusion criteria: 1. Patients with wounds caused by venous or arterial insufficiency, or electrical or chemical burns 2. Patients with wounds showing presence of necrosis, purulence or sinus tracts that cannot be removed by debridement 3. Patients with history of active Charcoatâ??s foot of the study foot within 6 months of screening 4. Patients with severe or poorly controlled diabetes mellitus with severe hyperglycaemia (HbA1C >12%) 5. Patients with progressive weight loss 6. Patients undergoing treatment with corticosteroids, immunosuppressive or chemotherapeutic agents, or radiotherapy 7. Patients with history of other diseases, which can alter the normal healing of the wound such as connective tissue disease, renal failure, liver failure, and malignancy 8. Patients who underwent revascularization surgery in the last 8 weeks 9. Patients with ankle-brachial index(ABI) 10. Pregnant or lactating mothers

Design outcomes

Primary

MeasureTime frame
The percentage of wound contraction as calculated by using the initial and final area every week for 8 weeks by using graded sterile centimeter ruler sterile scaleTimepoint: Day 7, 14, 21, 28, 35, 42, 49 & 56

Secondary

MeasureTime frame
Subject satisfaction of wound healing using 5-point scaleTimepoint: Day 7, 14, 21, 28, 35, 42, 49 & 56;To assess adverse eventsTimepoint: Day 7, 14, 21, 28, 35, 42, 49 & 56;Visual analogue scale (VAS) is used to assess pain every week during dressing pad removalTimepoint: Day 7, 14, 21, 28, 35, 42, 49 & 56;Wound dimensions, wound edge, type of tissue in the wound bed, the depth of the wound, exudate of the wound, Peri-wound skin and presence of infection/inflammation will be assessed by using RESVECH 2.0 scaleTimepoint: Day 1, 7, 14, 21, 28, 35, 42, 49 & 56;Wound360 version 1.1 application is used for wound characterization and photographyTimepoint: Day 1, 7, 14, 21, 28, 35, 42, 49 & 56

Countries

India

Contacts

Public ContactDr Sanjay Sharma

FootSecure clinic

sanjay@footsecure.com9980772658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026